Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.

Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, Peres L, Berthier C, Soilihi H, Raught B, de Thé H.

Cancer Cell. 2010 Jul 13;18(1):88-98. doi: 10.1016/j.ccr.2010.06.003.

2.

SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.

Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, Li H, Shi G, Cang H, Sun Y, Wang J, Wang W, Gao F, Yi J.

J Biol Chem. 2010 Apr 23;285(17):12906-15. doi: 10.1074/jbc.M109.071431. Epub 2010 Feb 24.

3.

An additional role for SUMO in ubiquitin-mediated proteolysis.

Geoffroy MC, Hay RT.

Nat Rev Mol Cell Biol. 2009 Aug;10(8):564-8. doi: 10.1038/nrm2707. Epub 2009 May 28. Review.

PMID:
19474794
4.

Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.

Percherancier Y, Germain-Desprez D, Galisson F, Mascle XH, Dianoux L, Estephan P, Chelbi-Alix MK, Aubry M.

J Biol Chem. 2009 Jun 12;284(24):16595-608. doi: 10.1074/jbc.M109.006387. Epub 2009 Apr 20.

5.

Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling.

Stehmeier P, Muller S.

Mol Cell. 2009 Feb 13;33(3):400-9. doi: 10.1016/j.molcel.2009.01.013.

6.

Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.

Evdokimov E, Sharma P, Lockett SJ, Lualdi M, Kuehn MR.

J Cell Sci. 2008 Dec 15;121(Pt 24):4106-13. doi: 10.1242/jcs.038570. Epub 2008 Nov 25.

7.

Dynamics of component exchange at PML nuclear bodies.

Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G, Hoischen C, Maul G, Dittrich P, Hemmerich P.

J Cell Sci. 2008 Aug 15;121(Pt 16):2731-43. doi: 10.1242/jcs.031922. Epub 2008 Jul 29.

8.

Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.

Gao C, Ho CC, Reineke E, Lam M, Cheng X, Stanya KJ, Liu Y, Chakraborty S, Shih HM, Kao HY.

Mol Cell Biol. 2008 Sep;28(18):5658-67. doi: 10.1128/MCB.00874-08. Epub 2008 Jul 14.

9.

Spatial mapping of splicing factor complexes involved in exon and intron definition.

Ellis JD, Llères D, Denegri M, Lamond AI, Cáceres JF.

J Cell Biol. 2008 Jun 16;181(6):921-34. doi: 10.1083/jcb.200710051.

10.

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.

Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT.

Nat Cell Biol. 2008 May;10(5):538-46. doi: 10.1038/ncb1716. Epub 2008 Apr 13.

PMID:
18408734
11.

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.

Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de Thé H.

Nat Cell Biol. 2008 May;10(5):547-55. doi: 10.1038/ncb1717. Epub 2008 Apr 13.

PMID:
18408733
12.

A SIM-ultaneous role for SUMO and ubiquitin.

Perry JJ, Tainer JA, Boddy MN.

Trends Biochem Sci. 2008 May;33(5):201-8. doi: 10.1016/j.tibs.2008.02.001. Epub 2008 Apr 9. Review.

PMID:
18403209
13.

Acute promyelocytic leukemia: from highly fatal to highly curable.

Wang ZY, Chen Z.

Blood. 2008 Mar 1;111(5):2505-15. doi: 10.1182/blood-2007-07-102798. Review.

14.

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.

Bernardi R, Pandolfi PP.

Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16. Review.

PMID:
17928811
15.

The mechanisms of PML-nuclear body formation.

Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP.

Mol Cell. 2006 Nov 3;24(3):331-9.

16.

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK.

J Virol. 2006 Sep;80(17):8582-92.

17.

In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.

Saitoh N, Uchimura Y, Tachibana T, Sugahara S, Saitoh H, Nakao M.

Exp Cell Res. 2006 May 1;312(8):1418-30.

PMID:
16688858
18.

The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.

Quimby BB, Yong-Gonzalez V, Anan T, Strunnikov AV, Dasso M.

Oncogene. 2006 May 18;25(21):2999-3005.

PMID:
16501610
19.

The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.

Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, Pandolfi PP, Dejean A.

Dev Cell. 2005 Dec;9(6):769-79.

20.

Proteasomes degrade proteins in focal subdomains of the human cell nucleus.

Rockel TD, Stuhlmann D, von Mikecz A.

J Cell Sci. 2005 Nov 15;118(Pt 22):5231-42. Epub 2005 Oct 25.

Supplemental Content

Support Center